|
""Oncorequisite"" Genes in MYC-mediated Transformation
|
5R00CA134743-05
|
$234,037
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma
|
5R21CA180063-02
|
$205,701
|
PEI, YANXIN
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
1R01CA185039-01
|
$386,223
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma
|
1R01CA183776-01
|
$309,175
|
LESSNICK, STEPHEN
|
UNIVERSITY OF UTAH
|
|
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
|
1R21CA189990-01
|
$193,575
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
1R01CA185402-01
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD2) Why is Endemic Burkitt Lymphoma Curable with Single Agent Chemotherapy?
|
5R21CA180097-02
|
$192,409
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
1R01CA174851-01A1
|
$648,487
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A Novel Epigenetic Circuit in Acute Leukemia
|
1R21CA187276-01
|
$169,650
|
HUANG, GANG
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A novel functional genomic pipeline for target identification in sarcoma
|
1R21CA187516-01
|
$211,451
|
AMATRUDA, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors
|
1K07CA174728-01A1
|
$164,851
|
RECUAY, KATIE
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
|
5K08CA140720-05
|
$149,387
|
DRULEY, TODD
|
WASHINGTON UNIVERSITY
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-02
|
$130,663
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
1K99CA175184-01A1
|
$180,360
|
IGNATIUS, MYRON
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-04
|
$315,542
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$381,093
|
Aplan, Peter
|
CCR (NCI)
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$2,555,132
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$613,610
|
Fry, Terry
|
CCR (NCI)
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$262,976
|
Fry, Terry
|
CCR (NCI)
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-09
|
$368,817
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-04
|
$170,100
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
5R01CA170250-03
|
$578,639
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
5R01CA129541-08
|
$312,849
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,360,387
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Anticancer Drug Pharmacology in Very Young Children
|
5R01CA154619-03
|
$420,471
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,416,689
|
Berzofsky, Jay
|
CCR (NCI)
|
|
ARID5B and disparities of childhood leukemia
|
1U01CA176063-01A1
|
$388,534
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Assessment of low dose and low dose-rate cancer risk
|
ZIA CP010132 - 10681
|
$2,756
|
Little, Mark
|
DCEG (NCI)
|
|
Assisted Reproductive Technology & Risk of Childhood Cancer
|
5R01CA151973-04
|
$575,881
|
LUKE, BARBARA
|
MICHIGAN STATE UNIVERSITY
|
|
Basic Mechanisms of Viral and Chemical Carcinogenesis
|
5T32CA009156-40
|
$1,272,857
|
PAGANO, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Bay Area Tumor Institute NCORP
|
1UG1CA189817-01
|
$698,719
|
GREIF, JON
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
|
5R01CA109821-10
|
$220,391
|
CHAMBERS, TIMOTHY
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-12S2
|
$129,070
|
ROBERTSON, JOHN
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Berberine downregulates MDM2 by interaction with DAXX in cancer cells
|
5R01CA143107-05
|
$65,349
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
BETR Therapy for Herpesvirus-Associated Tumors
|
5R01CA138636-05
|
$520,698
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS
|
ZIA BC 011002
|
$524,843
|
Khan, Javed
|
CCR (NCI)
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-20
|
$2,064,762
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Biology and Prognostic Implications of FLT3 Mutations in AML
|
5R01CA114563-08
|
$416,234
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-15
|
$1,925,523
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$358,240
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$557,103
|
Steinberg, Seth
|
CCR (NCI)
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
5R01CA168452-02
|
$258,230
|
CHOU, MARGARET
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|